Three COVID-19 clinical trials move forward at UW
The University of Wisconsin School of Medicine and Public Health and UW Health will conduct three clinical trials to test a new treatment and preventative for COVID-19, in collaboration with Regeneron Pharmaceuticals.
‘COVID toes’ clinical trial underway at UW School of Medicine and Public Health
A team of researchers at the University of Wisconsin School of Medicine and Public Health is studying how the skin condition referred to as “COVID toes” is a connected to the virus, whether it is symptom of a COVID-19 infection or an immune response to the virus.
First COVID-19 patient at University Hospital treated with plasma from recovered patient
A COVID-19 patient at UW Hospital has received the first transfusion of plasma from a local patient who donated it since recovering from the disease.
Scoring system predicts seizure risk in hospitalized patients
A new rating system can accurately predict which critically ill patients are in danger of having seizures while hospitalized, a large, multi-national trial shows.
Inflammation predicts response to anti-depression medication
Children and teens with bipolar depression responded better to an antipsychotic medicine if they had increased markers of inflammation in their blood, a new University of Wisconsin–Madison study shows.
Biostatistics and medical informatics tapped for $11.8 million national coordinating center
A University of Wisconsin-Madison professor and his team have been chosen to lead the nation’s coordinating center for the National Cancer Institute (NCI) Cancer Prevention Clinical Trials Network (CP-CTNet).
Elizabeth Nugent named chief clinical research officer
Elizabeth “Betsy” Nugent, MSPH, CCRP, will become the inaugural Director of Clinical Trials Development and Accreditation/Chief Clinical Research Officer, effective September 3. Nugent is charged with leading the establishment of the School of Medicine and Public Health and UW Health as a premier clinical research organization.
Can a sleep device give deep-space explorers a good night’s rest?
The Wisconsin Institute for Sleep and Consciousness (WISC) will be one of two sites for testing a device that might improve sleep and thus waking performance for people on long space voyages.
UW program for advanced cell therapy launches first clinical trial
For the first time in Wisconsin, a research team will test a personalized cell therapy to treat a common and serious complication in bone-marrow transplant patients.
First Carbone Cancer Center patient receives experimental therapy to prevent infections during chemotherapy
Michael Toelle, superintendent of the Tomorrow River Schools, recently became the first patient at the University of Wisconsin Carbone Cancer Center to be infused with an experimental cellular therapy designed to prevent infections in leukemia patients.
Clinical prospects for stem cells begin to emerge
Twenty years after the University of Wisconsin–Madison’s James Thomson derived the first human embryonic stem cell lines (ESC), his revolutionary discovery is just beginning to emerge on the clinical landscape.
UW to test using MDMA in treatment of severe PTSD
The Department of Family Medicine and Community Health of the UW School of Medicine and Public Health will take part in a multisite Food and Drug Administration-approved Phase III trial investigating MDMA as an adjunct to psychotherapy for the treatment of severe post-traumatic stress disorder (PTSD).